Sugammadex - Generic Drug Details
✉ Email this page to a colleague
Generic filers with tentative approvals for SUGAMMADEX
| Applicant | Application No. | Strength | Dosage Form |
| ⤷ Try for Free | ⤷ Try for Free | 500MG/5ML | INJECTABLE;INJECTION |
| ⤷ Try for Free | ⤷ Try for Free | 200MG/2ML | INJECTABLE;INJECTION |
| ⤷ Try for Free | ⤷ Try for Free | 500MG/5ML(100MG/ML) | INJECTABLE;INJECTION |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
US Patents and Regulatory Information for sugammadex
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | AP | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
| Zydus Pharms | SUGAMMADEX SODIUM | sugammadex sodium | SOLUTION;INTRAVENOUS | 214290-002 | Oct 4, 2023 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
| Aspiro | SUGAMMADEX SODIUM | sugammadex sodium | SOLUTION;INTRAVENOUS | 214337-002 | Jun 9, 2023 | AP | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Showing 1 to 3 of 3 entries
